Bipartisan Marijuana Data Collection Act Would Gather Info On Legal State Cannabis Markets

April 29, 2021 4:51 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Bipartisan Marijuana Data Collection Act Would Gather Info On Legal State Cannabis Markets

On Thursday, U.S. lawmakers introduced a bipartisan, bicameral bill to study the various impacts of state-legalized cannabis programs.

The Marijuana Data Collection Act is being sponsored by an across-the-aisle effort of senators and representatives with noted track records of cannabis support:

  • Sen. Bob Menendez (D-N.J.)
  • Sen. Rand Paul (R-KY)
  • U.S. Rep. Sylvia Garcia (D-TX-29)
  • U.S. Rep. Don Young (R-AK)

What's In The Marijuana Data Collection Act?

The bill would assess both medical and recreational cannabis programs and their economic, public health, criminal justice and workplace effects.

The study would also look at revenue streams generated by legal marijuana markets, how the revenue is used and how it impacts state budgets.  

Aside from financial metrics, the study would look at consumption among population groups, medicinal usage and the impact of cannabis on the opioid crisis.

Sponsors are seeking a 10-year partnership with the National Academy of Sciences and prominent government officials and agencies, including the secretary of health and human services, Attorney General, secretary of labor and other relevant state and health agencies.

Findings from the study would be submitted to Congress every two years over the next decade and made public.

Along with bipartisan congressional support, the bill has the backing of several prominent cannabis advocacy groups such as NORML, the National Cannabis Industry Association and the Minority Cannabis Business Association.

Recent Congressional Cannabis Reform Efforts

The bill is the latest piece of legislation in a congressional session that's apparently open to discussing cannabis reform.

The Marijuana Data Collection Act joins the CLAIM Act, which Menendez and Paul introduced in March. The bill is aimed at providing insurance options to legal cannabis businesses.

In a press release, NORML political director Justin Strekal said the bill is a data collection effort and not necessarily aimed at reform.

"No member of Congress can intellectually justify opposition to this legislation unless they are willing to deny the fact that the majority of American states are in defiance of the Schedule 1 criminalized status of cannabis," Strekal said. 

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.

Related Articles

The Week In Cannabis: Federal Research Bill, George Lopez, Brazil, Morocco, Columbia Care And More

As we near the end of the first half of 2021, we can see cannabis stocks traded mostly up by double digits, with the Amplify Seymour Cannabis ETF (NYSE: CNBS) delivering gains of more than 50% year-to-date. This week, however, stocks posted mixed performances. read more

Cannabis Movers & Shakers: Trulieve, Decibel, MediaCentral, Pelorus Equity Group

Trulieve Strengthens Board With Two Female Additions Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) has elected eight nominees to the board of directors during its annual and special shareholders meeting held on June 10, including new additions Giannella Alvarez and Jane Morreau. read more

The Arcview Group Teams Up With Zuber Lawler and GrowFlow To Boost Development Of Cannabis Businesses

The Arcview Group has partnered with law firm Zuber Lawler and GrowFlow to help those interested in starting a cannabis business. GrowFlow is an end-to-end inventory management, compliance and point of sale system for all legal cannabis markets. read more

Incarcerated 'Tiger King' Star Joe Exotic To Launch Cannabis Line

Joe Exotic is not letting a 22-year prison sentence get in the way of his entrepreneurial spirit. read more